Subscribe
|
Contact Us
|
Exosome Diagnostics Closes $20 Million Series A
Thursday, May 13, 2010
5:29:00 AM PDT | VentureDeal Staff
New York, New York -- Biotechnology diagnostics company
Exosome Diagnostics
has secured $20 million in its first round of venture capital investment.
Exosome is developing what it calls a next-generation body fluid-based oncology diagnostics platform.
NGN Capital and Forbion Capital Partners co-led the round. The company said it would use the funding to further develop and commercialize its platform.
Email Page
|
Print Page
Loading
Want unlimited access to the
complete database
with thousands of technology companies, VCs and transactions for only $25 per month?
Start your
Free 14 Day Trial
now – no obligation or credit card required.
